US Patent Issued to HUBIT GENOMIX, NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT on March 3 for "Method for primary prevention of allergic disorders during infancy through IgE-class-specific immunosuppression" (Japanese, American Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,539, issued on March 3, was assigned to HUBIT GENOMIX INC. (Tokyo) and NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT (Tokyo).

"Method for primary prevention of allergic disorders during infancy through IgE-class-specific immunosuppression" was invented by Hirohisa Saito (Saitama, Japan), Kenji Matsumoto (Tokyo), Hideaki Morita (Tokyo), Go Ichien (Tokyo), Yasuhiko Koezuka (Tokyo) and Kimishige Ishizaka (Carlisle, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a pharmaceutical composition containing an anti-IgE antibody that suppresses the production of allergen-specific IgE antibodies and methods of use thereof."

The...